Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Research Applications: When to Use Epithalon vs Pinealon

Epithalon is the standard choice for longevity research models where the endpoint is lifespan extension, age-related disease delay, or cellular senescence markers. The peptide has demonstrated efficacy in multiple species: C. elegans lifespan increased by 18%,

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Epithalon is the standard choice for longevity research models where the endpoint is lifespan extension, age-related disease delay, or cellular senescence markers. The peptide has demonstrated efficacy in multiple species: C. elegans lifespan increased by 18%, Drosophila by 12%, and rodent models by 10–15% depending on administration timing. Human trials are limited, but observational data from clinical use in Russia (where Epithalon has been available since the 1990s) suggests measurable improvements in immune function markers (CD4/CD8 ratio normalization) and circadian rhythm restoration in elderly populations.
  • Pinealon is used exclusively in neuroscience contexts. Traumatic brain injury models, neurodegenerative disease progression (Alzheimer's, Parkinson's), cognitive decline, and post-stroke recovery. Its neuroprotective effects are well-documented: a randomized controlled trial in stroke patients (n=60) found that Pinealon administration within 24 hours of ischemic event reduced infarct volume by 22% compared to placebo and improved NIH Stroke Scale scores at 30 days. Cognitive testing (MMSE, MoCA) showed statistically significant improvements in memory recall and executive function tasks in the Pinealon group.
  • The application decision matrix: if the research question involves replicative aging, cellular turnover, or systemic longevity markers (telomere length, epigenetic age clocks, mitochondrial function across tissues), Epithalon is the peptide of choice. If the research question involves neuronal survival, synaptic plasticity, neurotransmitter balance, or recovery from CNS injury, Pinealon is mechanistically appropriate. We've reviewed protocols from hundreds of research institutions. The ones that achieve reproducible results use this application logic, not peptide availability or cost.